Search Results (1 to 10 of 2904 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 826 Journal of Medical Internet Research
- 552 JMIR Research Protocols
- 321 JMIR Formative Research
- 253 JMIR mHealth and uHealth
- 111 JMIR Public Health and Surveillance
- 109 JMIR Mental Health
- 106 Online Journal of Public Health Informatics
- 83 JMIR Medical Informatics
- 79 JMIR Human Factors
- 72 JMIR Cancer
- 54 JMIR Pediatrics and Parenting
- 45 JMIR Aging
- 44 JMIR Serious Games
- 35 JMIR Medical Education
- 29 JMIR Diabetes
- 24 JMIR Perioperative Medicine
- 23 Interactive Journal of Medical Research
- 19 JMIR Rehabilitation and Assistive Technologies
- 17 JMIR Cardio
- 17 JMIR Dermatology
- 17 JMIR Infodemiology
- 15 Iproceedings
- 10 JMIR AI
- 10 JMIRx Med
- 9 JMIR Nursing
- 9 Journal of Participatory Medicine
- 6 JMIR Bioinformatics and Biotechnology
- 4 JMIR Biomedical Engineering
- 2 Asian/Pacific Island Nursing Journal
- 2 Medicine 2.0
- 1 JMIR Neurotechnology
- 0 iProceedings
- 0 JMIR Preprints
- 0 JMIR Challenges
- 0 JMIR Data
- 0 JMIRx Bio
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR XR and Spatial Computing (JMXR)
Go back to the top of the page Skip and go to footer section
deal: samen werken aan duurzame zorg [Article in Dutch](https://www.rvo.nl/sites/default/files/2024-12/C-
J Med Internet Res 2025;27:e67538
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Participant identifiers beginning with “C” denote control arm participants, and those beginning with “I” indicate intervention arm participants in the results. We constructed three themes through our analysis: (1) making meaning of transitions in care; (2) perceptions and impact of the biopsychosocial transition intervention; and (3) considerations for future transition care, including the importance of tailored supports.
JMIR Pediatr Parent 2025;8:e64618
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
(C) Decision support tool recommendation.
The care team could always override the recommendation of the decision support system. In the case of missing e PRO or laboratory data (or if the data were >3 days old) before the chemotherapy cycle, the decision support tool gave a tier-2 (yellow/evaluate) recommendation; thus, manual evaluation had to be done prior to prescribing the treatment. The SMS messaging module was used to inform the patient about the recommendation and potential treatment decision.
JMIR Form Res 2025;9:e62749
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
Several recent Canadian population-based studies have shown that many patients at high CVD risk continue to have low-density lipoprotein cholesterol (LDL-C) levels well above the guideline targets [2,3]. LDL-C has been extensively studied and described as a causal factor for CVD [4]. LDL-C levels above the target can result from multiple factors such as insufficient LDL-C lowering with statins, statin-related side effects, suboptimal medication adherence, and treatment inertia [5].
JMIR Cardio 2025;9:e58124
Download Citation: END BibTex RIS